dr. brentjens on cd19-targeted t cells in cll and all
Published 10 years ago • 214 plays • Length 1:03Download video MP4
Download video MP3
Similar videos
-
1:37
dr. wierda on using cd19-targeted car t cells in cll
-
1:48
dr. brentjens discusses targets for car t-cell therapy
-
1:22
dr. brentjens on car t-cell therapy challenges
-
1:13
dr. brentjens on modifying t cells to treat hematologic cancers
-
1:01
findings for cd19-targeted car t cells in combination with ibrutinib in cll
-
1:31
dr. brentjens on obstacles with car t-cell therapy in hematologic malignancies
-
1:11
dr. brentjens on the application of car-modified t cell technology to a wide array of cancers
-
0:52
the potential of targeting non-malignant cells in the cll microenvironment
-
1:40
dr. brentjens discusses potential for car t-cell therapy in solid tumors
-
1:56
dr. renier brentjens on genetically-modified t cells
-
2:04
dr. brentjens on treatment with car-modified t cells
-
9:33
long-term trial supports cd19-targeted car t cells for relapsed/refractory cll
-
1:10
dr. mccloskey discusses targeting cd19 in b-cell all
-
1:24
dr. park on using cd19-targeted car t cells as treatment for all
-
4:24
key questions in the field of cd19 car t-cell therapy
-
1:38
dr. brander on targeted agents in cll
-
1:59
efficacy and safety of cd19-targeted car t-cells for relapsed/refractory all
-
2:13
a targeted treatment with anti-cd19 car t-cells results in different responses
-
1:43
the co-administration of bispecific antibodies and car t-cells in cll: an in vivo study